Select Page

EpiVax will be in Tokyo Japan from September 14th-20th, 2014 hosting our semiannual immunogenicity seminar and meeting with collaborators. The Westin Immunogenicity Seminar is scheduled for September 17th, 2014. The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, deimmunization and tolerance induction).

Links

URI/EpiVax Immunogenicity Seminar 2014

Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island (URI) & EpiVax, Inc.

Venue: The Westin Tokyo

Wednesday, September 17th, 9:30 am – 5:00 pm
1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan

Chairs: Dr. Annie De Groot, Dr. Naonobu Sugiyama 

Speakers:

Dr. Naonobu Sugiyama, MD, PhD
JCR-board Certified Rheumatologist
Associate Director, RA & Inflammation
Medical Affairs Pfizer Japan

Prof. Annie De Groot, MD
Professor and Director, Institute of Immunology and Informatics,
University of Rhode Island, CEO/CSO, EpiVax, Inc.

Frances Terry
Bioinformatics Program Manager, EpiVax

Sandra Garces, MD, PhD
Department of Immunology, Instituto Gulbenkian de Ciencia, Portugal

Tomoyuki Igawa, PhD
Manager of Antibody Engineering Group, Chugai Pharmaceuticals

Futa Mimoto, PhD
Research Scientist, Discovery Division, Chugai Pharmaceuticals

Takuya Tsunoda, MD, PhD
President and CEO of OncoTherapy Science

Thank you for your interest, we hope to see you in Tokyo.

For more information: Email Us Here

Sign up for the seminar  – Sign up Here

Panel Discussion: Prof. Shimon Sakaguchi, Dr. Naonobu Sugiyama, Prof. Ken Ishii, Prof. David W. Scott, Prof. Annie De Groot

EpiVax Westin Immunogenicity Seminar, Osaka, 2013
Panel Discussion: Prof. Shimon Sakaguchi, Dr. Naonobu Sugiyama, Prof. Ken Ishii, Prof. David W. Scott, Prof. Annie De Groot

EpiVax Westin Immunogenicity Seminar, Osaka, 2013

EpiVax Westin Immunogenicity Seminar, Osaka, 2013